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DENV            Dengue virus 
DENV-1         Dengue virus type 1 
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Dengue is one of the mosquito-borne diseases of major importance in public health, 
which has spread worldwide, especially in tropical and subtropical regions, as a result of 
globalization, precarious urbanization, and expansion of the mosquito vector. Although 
it has been extensively studied at the molecular level, most of the dengue virus (DENV) 
genomes at public databases lack or have uncorroborated ends of the untranslated regions 
(UTRs), becoming a limitation when conducting studies of association between the 
genetic background of the virus and the clinical outcome of the disease. In an attempt to 
solve this problem, the present study aims to characterize the 5' and 3' ends of dengue 
virus, to provide complete information for future studies of viral pathogenesis.  The 5´ 
UTRs of twenty-seven Colombian DENV isolates (from patients with or without 
warning signs or severe disease) were readily amplified through a standard RACE 
approach while the 3´ UTRs required the development of a modified RACE protocol, 
For the cDNA synthesis of the 5' UTR, a specific anti-sense primer for each serotype 
was used, which were located at the coding region of the C or prM/M proteins. The 
cDNAs were purified and subsequently polyadenylated using the terminal transferase. 
By using an oligodT and an internal reverse primer located upstream of the first primer 
used for cDNA synthesis, the 5' UTRs were successfully PCR amplified and sequenced. 
For the molecular characterization of the 3' UTR, an adenine tail was directly added to 
the positive-sense viral RNA using the E coli poly (A) polymerase, which allowed the 
hybridization of the oligo-dT for the synthesis of cDNA, subsequent PCR amplifica t ion 
and Sanger sequencing. The results allow to demonstrate the successful characteriza t ion 
of the whole dengue virus UTRs and to assess the potential impact of point mutations at 
the RNA secondary structure level. 
 
Keywords: Genome ends, sequencing, dengue virus, RACE, E. coli Poly (A) polymerase. 
  
2. Introduction    
Dengue is considered to be one of the most important arthropod borne pathogens, since the 
number of infected individuals has increased in the last two decades (Brathwaite Dick et al., 
2012). It has been estimated that 50 to 100 million infections occur worldwide each year; In 
addition, infections occur in approximately 100 countries in the Asian-Pacific region, 
Americas, Middle East and Africa (Brathwaite Dick et al., 2012; WHO, 2009). Dengue may 
manifest in the host in two ways; Asymptomatic and symptomatic, the former may be 
presented as DF (Dengue Fever), Dengue Hemorrhagic Fever (DHF) or Dengue Shock 
Syndrome (DSS), or dengue without or with warming signs and severe dengue, according to 
the more recent WHO classification (WHO, 2009). Currently, other atypical manifestat ions 
involving the damage of body organs or systems known as "severe forms of dengue with 
organ compromise" and frequently associated with extreme severity and death are 
recognized (Salgado, 2008). 
Dengue virus (DENV) is transmitted through the bite of infected female mosquitoes 
belonging to the genus Aedes, mainly Aedes aegypti, which is distributed in tropical and 
subtropical countries, where about 3.6 billion people live (Rodriguez-Roche & Gould, 2013). 
The life cycle of the DENV begins when the mosquito feeds on the blood of an infected 
person, generating the infection of the mosquito midgut epithelial cells; then, the viral 
particles generated in these cells are released to invade other organs such as the salivary 
glands; The infection of the human host occurs when the mosquito injects its saliva-  
containing DENV particles during the blood meal (Velandia & Castellanos, 2011). 
DENV is a serocomplex of four globally distributed and closely related species (serotypes 
DENV-1, -2, -3 and -4) belonging to the family Flaviviridae, genus Flavivirus (Lindenbach 
et al., 2013; (Twiddy et al., 2002). Its genome consists of a positive-sense single-stranded 
RNA of about 11 Kb, which encodes for three structural (capsid, pre-membrane and 
envelope) and seven nonstructural (NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5) 
proteins (Guzman et al., 2010). At the 5' and 3' untranslated regions (5’ and 3’ UTR, 
respectively), the DENV genome contains several evolutionarily conserved structural 
elements involved in viral protein synthesis, genome replication and pathogenesis (Bäck & 
Lundkvist, 2013; Chiu, Kinney, & Dreher, 2005; Hussain & Asgari, 2014; Yu, Nomaguchi, 
Padmanabhan, & Markoff, 2008).  
The 5' UTR has a length of 95 to 101 nucleotides and contains two structural domains, the 
stem-loop A (SLA) and the stem-loop B (SLB) (Selisko, Wang, Harris, & Canard, 2014), in 
addition to the 5' UAR (5’ upstream AUG region) element that is complimentary to the 3' 
UAR during genome circularization. Two regions of the SLA domain interact with the viral 
RNA-dependent RNA polymerase (RdRp) promoting viral RNA synthesis. The SLB domain 
contains a 16-nucleotide-long (5’ UAR) that together with the 5’ cyclization sequence (5’ 
CS) is involved in genome cyclization, an essential process for viral replication (Filomato r i, 
Iglesias, Villordo, Alvarez, & Gamarnik, 2011; Friebe & Harris, 2010).  
Moreover, the 3' UTR comprises a stretch between 384 and 462 nucleotides and lacks of a 
poly (A) tail. It is composed of three domains (I, II and III). The domain I, also known as 
variable region (VR) extends about 50 to 120 nucleotides and is located just after the 
polyprotein stop codon (Zhou et al., 2006). It was recently reported that this region contains 
a viral miRNA with a role in DENV autoregulation in C6/36 cells by targeting the coding 
sequence of the viral NS1 protein (Hussain & Asgari, 2014). The domain II includes a DB 
(Dumbbell) structure with a double tandem repeat containing the conserved sequences CS2 
and RCS2 (repeated CS2), these conserved sequences were proposed to be involved in viral 
translation and RNA synthesis (Gebhard, Filomatori, & Gamarnik, 2011). Finally, the 
domain III is the most conserved region of the DENV 3' UTR and contains two elements. 
The first one is the 3' conserved cyclization sequence (3’ CS), a short element of 11 
nucleotides complementary to the 5' CS located at the capsid-coding sequence (Filomato r i 
et al., 2011). The second one is the 3’ stem-loop structure (3' SL) with approximately 79 
nucleotides in length (Paranjape & Harris, 2010). This element contains the 3' UAR sequence 
which is complementary to the 5' UAR at the 5' UTR. Both elements (3’ CS and 3’ SL) 
promote the genome circularization through base pairing with its complimentary 5’ sequence 
enabling the binding DENV and host proteins implicated in genome replication and protein 
translation. 
Although the genome of DENV has been extensively studied at the molecular level, most of 
the available whole-genome DENV sequences at GenBank have incomplete or 
uncorroborated 5´ and 3´ UTRs due to limitations in the conventional techniques of reverse 
transcription and subsequent PCR amplification, which involves the use of oligonucleotides 
with known consensus sequences. In addition, the lack of a poly (A) tail at the 3’ UTR 
hinders the use of most of the commercially available kits for amplification of 3’ UTR 
sequences based on the oligodT complementarity. 
Given the critical role of the 5’ and 3’ UTRs in DENV biology, the uncertainty of these 
regions becomes a constraint for studies involving full-genome comparisons, identifica t ion 
of genetic diversity and their potential role in pathogenesis and severe disease. Here, we 
present a strategy for reverse transcription and PCR amplification of the complete 5' and 3' 
UTRs of the four DENV serotypes, its performance in positive viral isolates of dengue from 





3.1. General objective 
To standardize and implement the characterization of the 5' and 3' UTRs of the genome 
of dengue virus serotypes 1, 3 and 4, as a potentially useful tool in studies of viral 
pathogenesis. 
 
3.2. Specific objective  
 To characterize the 5' and 3' UTRs of the genome of 15 DENV strains isolated from 
patients with dengue and severe dengue in Colombia, by rapid amplification of 
cDNA ends (RACE) and direct Sanger sequencing. 
 To evaluate alterations in the secondary RNA structure of the 5' and 3' UTR of the 
dengue virus genome, caused by point mutations in Colombian strains. 
  
 
4. Materials and methods 
4.1.Cell cultures and viral isolation 
Human sera from DENV-infected patients were diluted (1/100) in Eagle´s Minimal Essentia l 
Medium (E-MEM) supplemented with 1% HEPES, 1% NaHCO3, 5% Tryptose and 2% fetal 
bovine serum. Subsequently, C6/36 cell monolayers were inoculated with 200 µL of each 
diluted serum. Viral adhesion was carried out at 28 °C in a 5% CO2 atmosphere during 1 
hour, afterwards 800 µL of supplemented E-MEM were added. The cultures were incubated 
at 28 ºC, 5% CO2 atmosphere until cytopathic effect (CE) typically syncytia or cell growth 
arrest was observed without exceeding 14 days. A second passage for samples without 
showing CE was performed by transferring a 200 µL aliquot of the cell supernatant from the 
first passage to a fresh C6/36 monolayer. Culture supernatants were collected, cleared, 
aliquoted and stored at -80ºC.  
 
4.2. Viral RNA extraction 
The commercial QIAamp Viral RNA Mini Kit (Qiagen®, Chatsworth, CA, USA) was used 
for viral RNA extraction by following the manufacturer's recommendations. Briefly, a 
volume of 140 μl of each serum sample or cell culture supernatant (viral isolation) was mixed 
with 560 μl of AVL buffer containing carrier RNA. Then, 500 μl of absolute ethanol were 
added and the total volume transferred to a silica gel-based mini spin column and centrifuged 
at 8000 rpm. Subsequently, two washing steps were performed by adding 500 μl of AW1 
buffer and 500 μl of AW2 to remove residual contaminants by centrifuging at 8000 and 
13000 rpm, respectively. Finally, the elution was performed by the addition of 60 μL of AVE 
buffer to the column, incubating for 1 min at room temperature and centrifuging at 8000 rpm 
for 1 min. The purified RNAs were used for DENV serotyping in the virology laboratory of 
the National Institute of Health; using nested RT-PCR using improved oligonucleotides 
(Usme, Gómez, & Gallego, 2012), and stored at -70°C for subsequent cDNA synthesis.  
 
4.3. Primer designing for amplification of the DENV 5′ and 3′  untranslated regions (UTRs)  
 
Following the 5'/3' RACE kit 2nd generation (Roche Diagnostics GmbH, Mannheim, 
Germany) manufacturer´s recommendations, three specific antisense (SP1, SP2 and SP3) 
and two sense (SP4 and SP5) primers were designed for cDNA synthesis and PCR 
amplification of the 5' and 3' UTR regions of all DENV serotypes. Primer design was carried 
out using the parameters described in Table 1, through the PrimerSelect module of the 
LaserGene® suite version 8.1 (DNASTAR Inc., Madison, WI, USA.). The genomic 
sequences of four DENV isolates GQ868568 (DENV-1), NC_001474 (DENV-2), 
GU131954 (DENV-3) and GQ868585 (DENV-4) were used as reference. Once the best 
primer candidates were identified, they were aligned against several DENV strains reported 
in South American countries (Brazil, Peru, Venezuela, Ecuador, Argentina, Chile and 
Paraguay), in order to assess and consider the genetic variability from this region. The 
primers were finally designed by following parameters such as the 3'-OH of the primer 
coincident with the second or first codon position (for those located in the coding region), 
the inclusion of degenerate sites for those nucleotide positions with representative variability 
of DENV strains through the South American region. Degenerate sites were introduced 
according to the IUPAC nucleotide ambiguity code, available at: 
http://www.chick.manchester.ac.uk/SiteSeer/IUPAC_codes.html.   
The use of the previously designed anti-sense primers extending through the C or prM/M 
coding region (between positions 298 and 579, respect to each reference sequence) allowed 
the successful amplification of the 5' end of Colombian DENV-2 strains. Sense primers 
extending from the NS5 coding region and the 3’UTR (between positions 10114 and 10333, 
respect to each reference sequence) were successfully used for the molecular 
characterization of the 3' end. The PCR products were easily visualized through agarose gel 
electrophoresis showing a specific amplification that, allowed the direct purification and 
sequencing. 
Table 1. Characteristics that were considered for the design of the primers for the 






Characteristics  Minimum Maximum 
Length primers 17 bp 24 bp 
Melting 35.8ºC 62.5ºC 
Stability 3' pentamer 8.5 -Kc/M  
unique sequence in the 3' 7 bp  
 
4.4. Reverse transcription and PCR amplification of the 5´ untranslated region 
 
Serotype specific anti-sense primer SP1 (12,5 pmol), 5 µL (100-200ng) of total RNA 
extracted from DENV infected C6/36 cell supernatants, 1 mM dNTPs, 25 U Transcriptor 
Reverse Transcriptase (Roche Diagnostics GmbH, Mannheim, Germany), 1X cDNA 
synthesis buffer and 5 U RNaseOUT (Life Technologies, Carlsbad, CA, USA) were used for 
the cDNA synthesis of the 5' end. The mixture was incubated for 60 min at 55°C, then, 
reverse transcriptase was inactivated by heating at 85°C for 5 min. The cDNA products were 
purified using QIAquick PCR Purification Kit (Qiagen®, Chatsworth, CA, USA) following 
the manufacturer´s instructions. Poly (A) tailing of the first-strand cDNA using a 
recombinant terminal transferase and PCR amplification of dA-tailed cDNA were performed 
according to the 5'/ 3' RACE kit 2nd generation manufacturer’s instructions. The expected 
sizes of the PCR products generated with the SP2 primer were 453, 380, 448 and 477 for 
DENV1, 2, 3 and 4 respectively; while for the SP3 primer expected sizes were 310, 300, 298 
and 321 for DENV1, 2, 3 and 4 respectively. 
 
4.5. Poly A tailing reverse transcription and PCR amplification of the 3´ untranslated 
region 
In view that RNA extracts from infected cell supernatants contain nearly exclusive ly 
positive-sense DENV genomes and the DENV genome lacks of a poly (A) tail, it is not 
possible to use specific forward primers (SP4 or SP5) or oligo-dT for cDNA synthesis. 
Therefore, the strategy consisted in the direct adenylation of positive-sense DENV RNA 
genomes Briefly, 15 µL of total RNA (~500ng) were poly-adenylated at the 3' end in a 
reaction mixture containing 0.5 units of E. coli poly (A) polymerase system (New England 
Biolabs), E. coli poly (A) polymerase reaction buffer (50 mM Tris-HCl, 250 mM NaCl, 10 
mM MgCl2) and 1mM adenosine-5'-triphosphate (ATP) followed by incubation 37°C for 30 
minutes. Afterwards, 5 µL from the previous reaction were used in cDNA synthesis reaction 
using high capacity cDNA reverse transcription kit (Applied Biosystems) the reaction mix 
included 12.5 pmol of the oligo-dT anchor primer (5’-GAC CAC GCG TAT CGA TGT 
CGA C-TTT TTT TTT TTT TV-3’), 1X RT-buffer (50 mM KCl, 10 mM Tris-HCl, pH 8.3), 
1mM dNTPs, 50 U MultiScribe™ reverse transcriptase and 5 units of RNaseOUT. The 
reaction mix was incubated at 58°C for 45 min, then 85°C for 5 min. Next, the PCR step was  
performed using 5 µL from the previous reaction, 37.5 pmol of oligo-dT, anchor primer 12.5 
pmol of serotype-specific SP5 primer, 1.25 U Taq DNA polymerase (Thermo Fisher 
Scientific, Carlsbad, CA, USA), 1X PCR buffer, (20 mM Tris-HCl pH 8.4, 50 mM KCl), 2 
mM MgCl2, 1mM dNTPs and nuclease-free water for a final volume of 50 μL. The mixture 
was incubated at 95°C for an initial 5 min denaturation step, followed by 45 cycles (95°C 
for 30 sec, 50°C for 30 sec, 72°C for 90 sec), and a final extension at 72°C for 5 min. It was 
used in the PCR, sterile water as negative control and as a positive control it were used strains 
of each serotype previously typified of dengue virus. The expected sizes of the PCR products 
generated with the SP4 primer were 713, 563, 490 and 452, for DENV1, 2, 3 and 4, 
respectively, while for the SP5 primer the expected sizes were 581, 438, 389 and 389, for 
DENV1, 2, 3 and 4, respectively. 
4.6. DNA sequencing and sequence handling 
PCR products were purified by using the QIAquick PCR purification kit (Qiagen®, 
Chatsworth, CA, USA) and the expected sizes confirmed by agarose gel electrophores is. 
Around 40 ng of each purified amplicon were added to a sequencing reaction mixture 
containing 3 µL of BigDye® terminator cycle sequencing v3.1 (Applied Biosystems, 
Carlsbad, CA, USA), 3.2 pmol of the serotype-specific oligonucleotide, and 2 µL of 5X 
sequencing buffer (400 mM Tris-HCl, 10mM MgCI2), in a final volume of 10 µL. The 
thermal profile consisted of an initial denaturation step at 96°C for 1 min, followed by 25 
cycles (96°C for 10 sec, 50°C for 5 sec, 60°C for 4 min); The DNA fragments were purified 
through the BigDye® Xterminator purification kit (Applied Biosystems, Carlsbad, CA, 
USA), and subsequently processed by the ABI 3130 Genetic Analyzer (Applied Biosystems, 
Carlsbad, CA, USA). The electropherograms were visualized, edited and assembled through 
the SeqMan module of LaserGene® v8.1 (DNASTAR Inc., Madison, WI, USA.). 
4.7. Sequence alignment and evolutionarily-conserved RNA structure prediction 
Homologous sequences were aligned through the ClustalW algorithm implemented in 
MEGA version 7 (Kumar, Stecher, & Tamura, 2016). For comparison, some availab le 
complete genomes of the different serotypes of DENV circulating in South America were 
included in the analysis. The Basic Local Alignment Search Tool (BLAST) was used to 
verify the similarity of the obtained sequences in the present study. The Colombian 
sequences corresponding to the 5′ and 3′ UTR of each DENV serotype were used for 
prediction of secondary structures and the identification of evolutionarily-conserved RNA 
elements, through the use of RNAstructure and RNAz web servers, available at 
http://rna.urmc.rochester.edu/RNAstructureWeb/ and http://rna.tbi.univie.ac.at/cgi-
bin/RNAz/RNAz.cgi, respectively; on the other hand, the RNAfold software was used as a 
tool to have a general overview of the pertaining secondary structures at the DENV UTR, 
available at http://rna.tbi.univie.ac.at/cgi-bin/RNAWebSuite/RNAfold.cgi. 
5. Results  
5.1. Amplification of the 5' UTR of all DENV serotypes   
Following the strategy described in Materials and Methods, serotype-specific primers (SP1, 
SP2 and SP3) were designed for amplification of the 5' end of the DENV genome (Table 2). 
The 5' UTR of Colombian strains corresponding to the four DENV serotypes was 
successfully amplified by using the standard RACE approach that involved the 
polyadenylation of the cDNA generated with the primer SP1 (Figure 1a), However, in the 
first round of PCR amplification (with serotype-specific primer SP2), bands of the expected 
size were only observed for isolates of DENV-2 and -3. While in the second PCR round 
(with serotype-specific primer SP3), bands of the expected size were observed for all DENV 
serotypes. (Figure 2). The cycling conditions consisted of an initial denaturation at 95°C for 
2 min, 40 cycles of denaturation (95°C for 20 sec), annealing (30 sec at 58°C for DENV-1 
and DENV-3) or 50°C for DENV-4), and extension (72°C for 30 sec), with a final extension 
at 72°C for 7 min. 
Table 2. Serotype-specific primers used for amplification and sequencing of the 5' and 3' 








Sequence (5´- 3´)b TM 
DENV-1 
DENV1_SP1 Antisense 5´ 560-579 CCGGGGGCATTTGTAGGTCA 59.1ºC 
DENV1_SP2 Antisense 5´ 431-453 TATCATGTGTGGCTCTCCYCCTC 54.7ºC 
DENV1_SP3 Antisense 5´ 287-310 CTTTGATYGCTCCATTCTTCTTGA 56.5ºC 
DENV1_SP4 sense 3´ 9949 – 9970 CACCAATGGATGACAACAGAAG 51.9ºC 
DENV1_SP5 
 
sense 3´ 10119 - 10140 CACCTGGGCCACCAACATACAA 59.1ºC 
DENV-2c 
 
DENV2_SP4 Sense 3´ 10114-10137 AGAACATCCAAACAGCAATAAATC 59.0ºC 
DENV2_SP5 Sense 3´ 10238-10262 AAGGGAAGAGGAAGAGGCAGGTGT 61.8ºC 











Antisense 5´ 560-579 GGTRATRTGGGGGCATTTGTAAG 53.6ºC 
Antisense 5´ 429-448 CGGCTCTCCATCTCGTGAAG 54.7ºC 
Antisense 5´ 276-298 CGACTTCTTGAAGGTTCCCCATC 57.7ºC 
sense 3´ 10210-10233 GAAGGAGGAGGARTCGGAGGG 55.7ºC 








Antisense 5´ 496-517 TTGTTGATCCCCTCTGTTGTYT 52.6ºC 
Antisense 5´ 454-477 CCCTTTCATGTTTTGCCACTATCA 56.9ºC 











      
a Genomic positions were estimated for every DENV serotype according to the sequences 
available in GenBank with accession numbers: GQ868568 (DENV-1), NC_001474  
(DENV-2) GU131954 (DENV-3) and GQ868585 (DENV-4). b Degenerate sites were 
included by following the IUPAC nucleotide ambiguity code. c DENV-2 primers were 
designed in a previous study by Laiton-Donato 2016. 
 
Fig. 1. Strategy for polyadenylation, cDNA synthesis and PCR amplification of the 5' and 3' ends of the DENV 
genome. a). Terminal transferase-based protocol for amplification of the 5´ end b). Poly (A) polymerase-based 
protocol for amplification of the 3´ end. V: A, C or G. adapted from the 5'/3' RACE kit 2nd generation 
(Roche Diagnostics GmbH, Mannheim, Germany). 
 
5.2. Amplification of the 3´ UTR of all DENV  serotypes 
For cell-free supernatants of infected C6/36 cells, the standard RACE approach was not 
expected to be an efficient method for the characterization of the DENV 3' UTR, because of 
the exclusive presence of positive-sense RNA genomes in the secreted viral particles. A first 
approach to overcome this limitation, consisted in applying the RACE strategy to total RNA 
extracts obtained from cell lysates, in which the presence of negative-sense viral RNA within 
dsRNA and replicative intermediates is expected (Chu & Westaway, 1985). This strategy 
was not successful (data not shown), possibly due to the asymmetric replication of the DENV 
genome, and therefore the low abundance of negative-sense viral RNA strands (Diamond, 
Edgil, Roberts, Lu, & Harris, 2000). A second and novel approach consisted in the poly-
adenylation of the positive-sense viral RNA by using the E. coli poly (A) polymerase, and 
subsequent oligo-dT hybridization on the artificially generated poly (A) tail (Figure 1b), 
which demonstrated to be successful for specific amplification of the 3' UTR of DENV -2, -
3 and -4. (Figure 3). The cycling conditions that were standardized for each serotype 
consisted of an initial denaturation of 95°C for 2 min, 30 cycles of denaturation at 95°C for 
20 sec, annealing for 30 sec at 52°C for DENV-2, 61°C for DENV-3 and 52°C for DENV-
4, and extension at 72°C for 30 sec), with a final extension at 72°C for 7 min, in case of 
DENV -3 and -4 were 40 cycles. DENV-1 strains were not. 
At the best of our knowledge, this novel poly (A) polymerase-based approach has not been 
previously used for molecular characterization of the 3’ UTR of positive-sense viral RNA 
genomes.  
 
Fig. 2. PCR amplification of the 5´end of dengue virus serotypes 1, 3 and 4. a), b) and c)  Nested 
PCR using SP2 or SP3 and oligodT anchor primers for successful amplification of DENV-1, -3 
and -4 strains, respectively. Previously characterized DENV strains were used as positive 
controls. The PCR product was 453, 448 and 321 bp in length for DENV-1, -3 and -4, respectively. 
MW: 100 bp DNA ladder (Invitrogen) were used in a) and b) with 600 bp and the PCR product 
of each serotype marked; on the other hand, c) 100 bp DNA ladder (Thermo Fisher) was used 




Fig. 3. PCR amplification of the 3´end of dengue virus serotypes 2, 3 and 4. a), b) and c). Nested 
PCR using SP4 and oligodT anchor primers for successful amplification of DENV-2, -3 and -4 
strains, respectively. Previously characterized DENV strains were used as positive controls. The 
PCR product was 563, 490 and 452 bp in length for DENV-2, -3 and -4, respectively. MW: 
GeneRuler 100 bp DNA ladder (Thermo Fisher) with 500 bp and the PCR product of each 
serotype marked. 
5.3. Molecular characterization of the 5' and 3' ends of the dengue virus genome  
The DENV 5´ and 3´ end sequences were obtained by Sanger sequencing with specific 
primers (SP2, SP3, SP4 or SP5), as no good quality sequences were obtained with oligo-dT 
primer as expected from the variable size of the poly (A) tract among DNA molecules. A 
total of 31 isolates from Colombian clinical samples were successfully sequenced, 26 
isolates belonged to patients with dengue without warning signs (3 from DENV-1, 10 from 
DENV-2, 10 from DENV-3 and 3 from DENV-4) and 5 from severe dengue  patients (all 
from DENV-2) (Table 3). The electropherograms allowed to confirm the presence of the 
artificially generated poly (A) tail (Figure 4). Currently available full- length genomes of 
Colombian DENV isolates available at GenBank have incomplete or uncorroborated 5’ and 
3´ ends, typically lacking the first or last ~20 nt at the 5´ and 3´ ends, respectively. Using the 
BLAST alignment tool (http://blast.ncbi.nlm.nih.gov/Blast.cgi) the sequences obtained in 
the present study matched with other DENV strains reported in American countries (Cuba, 
Haiti, Brazil, Peru, Venezuela, Ecuador, French Guiana, Argentina, Chile and Paraguay). 
Even though our approach yielded sequences of the 5’ and 3’ ends for most of the tested 
isolates, four isolates showed a shorter amplicon size at the 5´end characterized by the 
presence of the poly (A) tract at the position 134 (relative to the reference sequence 
NC_001474). Interestingly the isolates that showed this behavior also, showed a noticeable 
drop in the fluorescence signal in the electropherograms, from that position to the beginning 
(position 1 of the viral genome). 




















424735 58 2013 META 5´ DF  
427493 61 2013 TOLIMA 5´ DF  
450339 69 2015 CUNDINAMARCA 5´ DF  






423887 12 2013 PUTUMAYO 3´ DF  
427516 28 2013 CALDAS 3´ DF  
425334 41 2013 PUTUMAYO 3´ DF  
425817 44 2013 TOLIMA 3´ DF  
425819 46 3013 CUNDINAMARCA 3´ DF  
428702 56 2014 TOLIMA 3´ DF  
424233 59 2013 BOYACÁ 5´ / 3´ DF  
449418 62 2015 TOLIMA 5´ DF  
449308 66 2015 HUILA 5´ / 3´ DHF/mortal  
 449618 67 2015 HUILA 5´ DF  
 449510 68 2015 PUTUMAYO 5´ DF  
 434321 156 2014 META 3´ DF  






449683 57 2015 RISARALDA 5´ / 3´ DF  
449499 60 2015 RISARALDA 5´ / 3´ DF  
449415 63 2015 PUTUMAYO 5´ / 3´ DF  
449740 81 2015 SUCRE 5´ / 3´ DF  
449746 82 2015 RISARALDA 5´ / 3´ DF  
449255 84 2015 QUINDÍO 5´ / 3´ DF  
449326 85 2015 RISARALDA 5´ / 3´ DF  
449334 86 2015 BOYACÁ 5´ / 3´ DF  
449335 87 2015 BOYACÁ 5´ / 3´ DF  
Fig.4. Artificial polyadenylation at the 5' and 3' ends of the DENV genome. Electropherograms of 
the 5  ́ and 3´ends of representative strains of DENV-1 to DENV-4. The 5’ and 3’ ends were 
sequenced by using specific reverse and forward primer, respectively. 
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371813 88   5´ / 3´   
37178 89   5´ / 3´   









5.4.Evolutionarily conserved structural elements at the 5´ and 3´ untranslated regions of 
dengue virus  
 
The two highly conserved secondary structures corresponding to the stem-loop A (SLA) and 
SLB were identified at the 5´ UTR, as well as the conserved RNA elements 5' UAR and 5' 
CS. In addition, it was possible to identify and the cHP element extending to the capsid-
coding region (Figure 5A); On the other hand, at the 3' UTR the 3´ SL, DB1 and DB2 
secondary structures were found with their respective conserved sequences RCS2 and CS2; 













































































At the 5' UTR of DENV, the structure analyzes of the DENV-2 5´end of the strains that 
showed the late poly-A tail and which generated shorter sequences, were not able to obtain 
the secondary structures present in the 5´ end, since, when analyzing the late poly (A) tail 
was found in the position 134 which is after SLA and SLB structures, curiously, the position 
of the late poly (A) was the same in all four strains, although, , when the amplification test 
was repeated with a high fidelity Taq polymerase, bands with a smaller size than expected 
were obtained. On the other hand, two thermodynamically stable secondary structures were 
identified in serotypes 1, 3 and 4.The first structure corresponds to the SLA element and the 
second structure corresponds to the SLB element (Figure 6). 
   5´ UTR  




                                                                                   SLB 
    
                                       
    
 (B) DENV 3 
   
  
         
                                                                                                            
 (C) DENV 4
 
                                                                                                                     SLB 
                                          SLA     







Fig 6. Alignment and secondary structures present in the 5'utr region of DENV. A) alignment and 
structure of the SLA and SLB elements of DENV 1, B) alignment and structure of SLA and SLB 
elements of DENV 3 and C) alignment and structure of SLA and SLB elements of DENV 4. 
On the other hand, in the 3'UTR region, the DB2 and 3'SL elements were identified for 
serotypes 2, 3 and 4 (Figure 7). For all elements analyzed in both the 5'UTR region and the 
3'UTR, different parameters were determined that are related to their thermodynamic 
stability Table 4. 
 3´ UTR  
A) DENV 2  
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Fig 7. Alignment and secondary structures present in the 3' UTR region of DENV. A) Alignment and 
structure of the DB2 and 3´SL elements of DENV 2, B) Alignment and structure of DB2 and 3´SL elements 
of DENV 3 and C) Alignment and structure of DB2 and 3´SL elements of DENV 4. 
 
Table 4.  
Thermodynamic stability of the secondary structures present in the 5' and 3' UTR of DENV -1, -2, -3 
and -4. 
 
5.5. Coverage at the 5' and 3' ends of the DENV genome in previously reported sequences 
In order to assess the coverage at the 5’ and 3’ ends, previously reported sequences of DENV 
strains circulating in neighboring countries (Brazil, Peru, Venezuela, Ecuador, Argentina, 
Chile and Paraguay) were aligned with those of the present study. At least 20 nucleotides 
are missing in the previously published sequences and were successfully sequenced through 
the methods described here (Figure 8). At the 3’ end, the last nucleotide is called “N” to 
designate a variable position, this is a consequence of using a degenerate oligo-dT anchor 
primer containing A, C or G at the 3’ end (Figure 8B). At the 5’ end, the “N” is also present 
at the -1 position, therefore, it does not affect the sequence of interest (Figure 8A). 
  
Parameters 
DENV 1 DENV 2 DENV 3 DENV 4 
SLA SLB DB2 3´SL SLA SLB DB2 3´SL SLA SLB DB2 3´SL 










0-120 0-120 120-240 200-320 




93.75 93.75 99.00 98.67 98.87 98.87 99.0 98.25 99.44 99.44 100.00 94.17 
Covariance 
contribution 
0.00 0.00 -0.16 -0.16 -0.40 -0.40 0.00 0.00 0.00 0.00 0.00 1.48 
Mean  
z-score 




0.84 0.84 0.99 0.99 1.01 1.01 1.00 1.00 1.00 1.00 1.00 0.94 
 
Fig.8. Alignment of sequences obtained with reported in GenBank database. a) Sequences belonging to the end amplification of the 5' UTR 
region. b) Sequences belonging to the amplification of the 3' UTR region end. 
6. Discussion   
During the last two decades, the intense research in fundamental biology of DENV and other 
closely-related flaviviruses has allowed deciphering the role or function of almost all viral 
proteins during the virus life cycle. These studies have also allowed the identification of 
several genome features that explain some of the phenotypic differences at the virus 
replication or virus-host interaction and pathogenesis levels. Genome differences include the 
presence/absence of nucleotide substitutions and insertion/deletions in the coding and the 
untranslated regions. It has been shown that the replication capacity of a virus is 
indispensable at the time of deciphering key elements in the pathogenesis and virulence. The 
5´and 3´ UTR could harbor some important determinants of virulence (Leitmeyer et al., 
1999), for this reason, analyzing these regions through complete sequencing is mandatory. 
The DENV RNA-dependent RNA polymerase endows the DENV genome with a high 
mutation rate ranging from 4.5x 10-4 substitutions per site every year (s/s/y) for DENV-1 to 
9x10-4 s/s/y for DENV-3, with some differences according to the serotype (Falcón-Lezama 
et al., 2009). The unavoidable accumulation of genetic variation in the whole DENV genome 
suppose a challenge for sequence-based molecular methods and therefore justify the rational 
design of degenerated oligonucleotides that theoretically cover the existent genetic 
variability and perform well for a longer period of mutation accumulation. Here, we used 
the PrimerSelect module of the LaserGene suite, which integrates the Nearest Neighbor 
algorithm for ΔG and melting temperature (Tm, the temperature at which half of the 
oligonucleotides have hybridized with the sequence) calculation. Using this algorithm, it was 
possible to design primers that worked well at the time of amplifying and sequencing the 5' 
and 3' ends of the DENV genome. All oligonucleotide candidates were analyzed through 
sequence alignment to cover the existing variability of DENV strains across the region and 
to avoid the use of critical primer positions according to the evolutionary behavior (e.g. 
codon position); the criteria that were used in this design of primers have already been 
validated previously in the study carried out by (Usme et al., 2012) 
In this work we demonstrated the successful cDNA synthesis and PCR amplification of 
several strains of the different DENV serotypes through the use of specific and sometimes 
degenerated oligonucleotides. The strategy consisted in following the standard termina l 
transferase-based RACE protocol for the 5’ end characterization. 
The original RACE protocol for the 3’ end was intended to work directly with 
polyadenylated RNA (e.g. messenger RNA), so in the case of DENV it was necessary to 
attach a poly (A) tail at this end. Therefore, a novel approach for the 3’ end characteriza t ion 
was implemented using the E. coli poly (A) polymerase, which was based on the direct 
polyadenylation of the positive-sense viral RNA genomes previously extracted from 
supernatants of infected cells. The artificially generated poly (A) tail provided a target for 
the oligo-dT hybridization during the cDNA synthesis and subsequent PCR amplifica t ion 
following the standard RACE protocol. High quality electropherograms evidenced the 
successful incorporation of a poly (A) tract to the viral genome and the complete resolution 
of the 3’ end sequence of the analyzes DENV strains of serotypes 2, 3 and 4. There were 
technical problems for PCR amplification of the 3’ end of DENV-1, however, it was not 
possible to attribute the cause to the primer design, because several oligonucleotide sets were 
unsuccessfully used. 
The technical approach presented here could be routinely used as a complement to full-
genome sequencing through different methods, by increasing the coverage at the genome 
ends and allowing more accurate association studies to phenotypic characteristics. 
The vast majority of Colombian DENV full- length genomes available at GenBank lack the 
5' and 3' ends of the UTR, due to the limitations imposed by current RNA genome 
amplification techniques by reverse transcription and PCR, which involves the use of 
oligonucleotides with previously known sequences during cDNA synthesis or PCR 
amplification; On the other hand, it has not been possible to establish an optimal method for 
its amplification without the risk of losing the end (Christenbury et al., 2010). Next 
generation sequencing (NGS) technologies such as reversible terminator sequencing-by-
synthesis by Illumina have shown to work well for the characterization of full-length RNA 
genomes including the UTRs with a level of detail for analyzing viral quasispecies and the 
presence of multiple genotype variants in a single sample, however, the computationa l 
methods for assembling Illumina short reads and solve homopolymeric regions at the DENV 
UTRs are still challenging (Caraballo Cortes et al., 2016). Hence, the methods described 
here offers a simple, straightforward and cost-effective way to characterize the most 
representative UTR sequences of any DENV serotype. 
It has been shown that there are factors associated with the virus that contribute in a 
differential way to the development of the disease, known as determinants of virulence. 
These factors have been associated with the serotype and genotype of the virus and identified 
as with point mutations that directly affect the viral fitness and therefore the levels of viremia 
in the human host (Vaughn et al., 2000); Other studies suggest that virulence determinants 
are present randomly throughout the DENV genome (Daira Camacho et al., 2009; Daría 
Camacho, Ferrer, Tenorio, Franco, & Comach, 2012), associated with the envelope gene or 
located at the 5' and 3' UTR (Leitmeyer et al., 1999) where they are involved in the initia t ion 
of translation (You & Padmanabhan, 1999), and in the regulation of viral replicat ion; 
(Alvarez, De Lella Ezcurra, Fucito, & Gamarnik, 2005; Daira Camacho et al., 2009; Daría 
Camacho et al., 2012; Rico-Hesse et al., 1997). It has been considered that the more virulent 
strains are those with greater replicative capacity (Vaughn et al., 2000), therefore, the  in 
vitro characterization becomes an indirect way of evaluating its capacity to cause disease.  
In this work we modified the RACE protocol since, as already mentioned, this protocol 
works directly with messenger RNA so in the case of DENV it was necessary to attach a 
poly A tail at the 3' UTR end, with the enzyme E. coli Poly A polymerase was able to provide 
a site for the synthesis of the cDNA using an Oligo-dT and in this way when binding by base 
pairing with the Poly A tail it was possible to obtain the end of the non-coding 3' UTR region. 
Due to the successful incorporation of the adenine tail, it was possible to implement the 
RACE protocol and in this way to amplify and sequence the complete ends of the DENV. 
A deletion of 11 nucleotides in the variable region (VR) was observed in 3 strains of DENV-
3; when comparing these sequences from Brazil, Nicaragua and Singapore, but not in 
Colombian strains; Previous studies have demonstrated deletions and nucleotide variations 
in the (VR) within the same serotype (Aquino et al., 2006; Roche, Cassar, Laille, & Murgue, 
2007); In spite of these observations, a high conservation was also found in the 5'UAR, 5'CS 
elements present in the 5' UTR region and in the case of the 3' UTR two variations were 
observed in the elements DB1 and DB2; On the other hand, the elements 3'SL, 3'UAR, 3'CS 
were the most conserved, as expected, since these elements belong to domain III, which has 
been considered the most conserved region at the 3´UTR. (Iglesias & Gamarnik, 2011). 
When comparing the sequences of the elements present in the UTRs that were obtained in 
this work with those found in the work of  (Paranjape & Harris, 2010), it was found that both 
the SLB and 3'SL elements as well as the sequences 5'UAR, 5'CS, 3'CS and 3'UAR remained 
preserved; While in the elements SLA, cHP, and DB1 variations were found, just as in the 
CS2 sequence present in the DB2 element; on the other hand, with the RNAz software it was 
found that the structures analyzed for the 5' UTR region have an identity of ~ 97.18% at the 
nucleotide level, in addition, two secondary structures denominated SLA and SLB were 
shown in silico (Gebhard et al., 2011); In the 3' UTR region an identity of  98.18% was 
found, in this region two structures denominated DB2 and 3'SL were evidenced (Gebhard et 
al., 2011). Any mutation in regions that are highly structured such as UTRs could lead to 
alterations in the structure and that previous studies are known to be very important at 
functional level; this would explain why, no conformational changes were found in the 
secondary structures encountered, or other additional structures.  
At the time of analyzing the sequences of the 5' UTR ends of the four serotypes we found a 
double peak in the sequences and a premature adenine tail; (Añez, Heisey, Volkova, & Rios, 
2016) it was thought to be the result of the existence of a heterogeneous viral population that 
contains two master sequences whit almost the same frequency and different length due to 
insertion/deletion mutations. 
The study presents a novel technical approach to the DENV genome ends characterizat ion, 
which could contribute to the extension of the frontier of knowledge through the 
identification of genetic determinants of pathogenicity that lead to severe manifestations of 
dengue. 
7. Conclusions 
The methodology was successful for the amplification of the 5' and 3' UTR ends of the strains 
to be analyzed, a total of 31 Colombian DENV isolates were identified, 26 from dengue 
patients with no warning signs (3 from DENV-1, 10 from DENV-2, 10 from DENV-3 and 
3 from DENV-4) and 5 from severe dengue DENV-2); of which, it was possible to solve the 
complete ends of the DENV genome and to observe that although variations were found in 
some sequential structures, they did not generate any change in the structure. 
This study will provide new knowledge and an important tool for obtaining information from 
the ends of the viral genome for the evaluation of the effect of mutations on the secondary 
structure of RNA and its potential impact on viral replication and pathogenesis.  
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